How Peptide Purity Is Measured: HPLC and Mass Spectrometry

Peptide purity testing is the set of analytical procedures — principally reversed-phase high-performance liquid chromatography with ultraviolet detection, paired with mass spectrometry — used to estimate what proportion of a synthesized peptide lot is the intended sequence and to confirm the molecular identity of that material.

The two techniques answer different questions. Chromatography answers "how many distinct species are present, and in what proportion". Mass spectrometry answers "what is the mass of the species eluting here". Neither answers the other's question, and neither on its own establishes what fraction of a weighed powder is peptide.

What RP-HPLC separates, and on what basis

Mant et al. (2007) surveyed the HPLC modes applied to peptides: size-exclusion, ion-exchange, reversed-phase, and a mixed-mode hydrophilic interaction/cation-exchange approach. Reversed-phase is the mode used for routine purity work.

In reversed-phase mode a peptide partitions between a hydrophobic stationary phase, commonly C18-bonded silica, and an aqueous-organic mobile phase whose organic fraction rises across a programmed gradient. Retention is governed largely by the hydrophobicity of the residues the peptide presents to that phase, so deleting or substituting a single residue often shifts a by-product into a separate peak. The detector monitors ultraviolet absorbance, usually near 214 nm, where the backbone amide bond absorbs.

Fekete et al. (2012) reviewed how column chemistry, particle morphology, pore size, column temperature, gradient steepness and mobile-phase additive selection govern the separation of therapeutic peptides and proteins. Those parameters are not cosmetic. A shallow gradient can resolve an impurity that a steep gradient buries inside the main peak, so a purity percentage is a conditional statement about one method, not an intrinsic property of a lot.

Why area percent is not mass percent

A chromatographic purity figure is normally reported as area percent: the integrated area of the target peak divided by the total integrated area of all detected peaks. Two assumptions are buried in that arithmetic, and both fail to some degree.

The first is that equal amounts of different species produce equal peak areas. Kuipers and Gruppen (2007) measured the molar extinction coefficients of the twenty amino acids and of the peptide bond at 214 nm in the presence of acetonitrile and formic acid. They reported 923 M⁻¹ cm⁻¹ for the peptide bond, roughly thirty times lower than tryptophan and six times lower than phenylalanine, tyrosine and histidine; methionine was comparable to the peptide bond, and proline negligible as a free amino acid but around three times a peptide bond when internal to a chain. A species that has lost an aromatic residue therefore absorbs less per mole than the parent peptide and is under-represented in an area-percent calculation. Composition-based correction is possible, and is exactly what an uncorrected area percent omits.

The second assumption is that everything present is detected. Water, inorganic salts and the counterion are transparent at 214 nm. A lot can be 99% pure by area and still contain a substantial non-peptide mass fraction.

Mass spectrometry establishes identity, not quantity

Fenn et al. (1989), in Science, described electrospray ionization producing intact ions from large and fragile species in solution, with spectra obtained for biopolymers up to about 130,000 daltons. Electrospray generates a distribution of multiply charged ions that is deconvoluted to a single neutral mass; matrix-assisted laser desorption/ionization is the common alternative and tends to produce singly charged ions.

What either technique confirms is that a species of the expected mass is present in the sample. It does not establish how much. Ionization efficiency varies between species by orders of magnitude, so relative ion abundance is not a reliable proxy for relative molar abundance, and an MS trace should not be read as a purity measurement.

Steen and Mann (2004), in Nature Reviews Molecular Cell Biology, set out the fragmentation nomenclature and the principles by which a sequence is read from the fragment ion series in tandem mass spectrometry. Tandem experiments move beyond intact mass to residue order, which is what separates a correct sequence from a rearranged one of identical composition.

Where mass measurement is blind

Isobaric and isomeric species share a mass and cannot be separated by mass measurement alone. Maroto et al. (2024) addressed a clear case: assessing the purity of a cyclic peptide by mass spectrometry is difficult because the linear precursor and the cyclised product have identical masses. The authors evaluated energy-resolved mass spectrometry, using collision-induced dissociation across a range of excitation voltages, alongside mid-infrared microscopy, and reported that infrared calibration was linear across the full molar-ratio range while the energy-resolved MS models were linear only up to a linear-peptide molar ratio of 0.3, with energy-resolved MS giving the better limit of detection.

Stereochemistry is the other blind spot. D'Hondt et al. (2014) identified racemization during Fmoc-deprotection as a route to diastereomeric impurities in solid-phase synthesis. Diastereomers are often chromatographically separable but are indistinguishable by mass, so their detection depends on the chromatographic method rather than the spectrometer.

Orthogonal quantitation

Where an absolute quantity is required rather than a ratio, metrology laboratories combine methods. Melanson et al. (2018) assigned purity to a candidate certified reference material for angiotensin II using quantitative NMR of the intact peptide, isotope-dilution LC-MS/MS amino acid analysis after hydrolysis, and mass balance, in which purity is the summed mass fraction of everything identified. The counterion, measured by a validated fluorine-19 qNMR method, amounted to nearly 25% of the mass, and the final assigned value was 691 ± 9 mg/g (k = 2). Both the qNMR and LC-MS/MS results required correction for related peptide impurities.

Method comparison

What a purity statement needs alongside the number

• Column chemistry, dimensions and particle size.
• Mobile phase composition, additive, gradient profile and flow rate.
• Column temperature and run time.
• Detection wavelength and integration approach.
• The chromatogram itself, at a scale where minor peaks are visible.
• For mass spectrometry, ionization mode with theoretical and observed masses.

Without those, two purity figures cannot be compared. Independent verification is discussed under lab testing.

Regulatory status

Analytical characterisation is a quality-control exercise and confers no regulatory standing. A purity result is not an approval, a safety evaluation, or a finding about permitted applications. Materials described here are not approved by the FDA, are supplied for laboratory research use only, and are not for human or animal consumption; see the research use policy.

Frequently asked questions

Does a purity percentage describe the whole contents of a vial?

No. Area-percent purity describes the composition of the ultraviolet-absorbing material only. The fraction of the weighed powder that is peptide is a separate measurement, determined by amino acid analysis, quantitative NMR, or an HPLC assay against a characterised standard.

Why do two laboratories report different purities for one lot?

Because purity is method-dependent. Different column chemistries, gradient slopes, temperatures and detection wavelengths resolve different sets of impurities, and integration parameters affect how small peaks are counted. Divergent figures usually reflect divergent methods rather than an error.

Can storage conditions change an analytical result?

Yes. The degradation routes catalogued by D'Hondt et al. (2014) — including diketopiperazine, pyroglutamate and succinimide formation, and side-chain oxidation — proceed over time and are influenced by temperature and moisture. A certificate describes material as it stood on the analysis date; handling considerations are collected at peptide storage, and related preparation arithmetic at the peptide calculator and reconstitution notes.

Is high-resolution mass spectrometry a substitute for chromatography?

No. Higher mass accuracy narrows the range of elemental compositions consistent with an observed mass, but isomers and stereoisomers remain identical in mass at any resolution. Separation and mass measurement are complementary, not interchangeable.